2 biotech firms investing $228M to open plants in Puerto Rico

http://bit.ly/2MxjVZA points form the article: - 2 biotech firms
investing $228M to open plants in Puerto Rico - CytoImmune
Therapeutics, Inc. and Biosimilar Solutions, LLC will establish
operations in Puerto Rico to develop their biotechnology products.
- Biosimilar Sciences will work on biotech products, including a
COVID-19 vaccine. - Biosimilar’s current product portfolio has an
approximate market value of $30 billion. - Puerto Rico who helped
make our presence here possible have been supportive, a reflection
of the island’s commitment to performing on the highest level in
terms of life science manufacturing and business development, -
Puerto Rico Incentives Code (Act 60) and other assets to set up
their operations.